The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
Open accessAbstract
Background— Experimental interleukin-1 receptor antagonist gene overexpression has shown that interleukin-1 receptor antagonist is cardioprotective during global cardiac ischemia. The aim of the present study was to test the impact of an exogenous recombinant human interleukin-1 receptor antagonist (anakinra) in experimental acute myocardial infarction. Methods and Results— Two animal studies were conducted: one of immediate anakinra administration during ischemia in the mouse and one of delayed anakinra administration 24 hours after ischemia in the rat. Seventy-eight Institute of Cancer Research mice and 20 Wistar rats underwent surgical coronary artery ligation (or sham operation) and were treated with either anakinra 1 mg/kg or NaCl 0.9% (saline). Treatment was administered during surgery and then daily for 6 doses in the mice and starting on day 2 daily for 5 doses in the rats. Twenty-eight mice underwent infarct size assessment 24 hours after surgery, 6 saline-treated mice and 22 mice treated with increasing doses of anakinra (1 mg/kg [n=6], 10 mg/kg [n=6], and 100 mg/kg [n=10]); 6 mice were euthanized at 7 days for protein expression analysis. The remaining animals underwent transthoracic echocardiography before surgery and 7 days later just before death. Cardiomyocyte apoptosis was measured in the peri-infarct regions. The antiapoptotic effect of anakinra was tested in a primary rat cardiomyocyte culture during simulated ischemia and in vitro on caspase-1 and -9 activities. At 7 days, 15 of the 16 mice (94%) treated with anakinra were alive versus 11 of the 20 mice (55%) treated with saline ( P =0.013). No differences in infarct size at 24 hours compared with saline were observed with the 1- and 10-mg/kg doses, whereas a 13% reduction in infarct size was found with the 100-mg/kg dose ( P =0.015). Treatment with anakinra was associated with a significant reduction in cardiomyocyte apoptosis in both the immediate and delayed treatment groups (3.1±0.2% versus 0.5±0.3% [ P <0.001] and 4.2±0.4% versus 1.1±0.2% [ P <0.001], respectively). Compared with saline-treated animals, anakinra-treated mice and rats showed signs of more favorable ventricular remodeling. In vitro, anakinra significantly prevented apoptosis induced by simulated ischemia and inhibited caspase-1 and -9 activities. Conclusions— Administration of anakinra within 24 hours of acute myocardial infarction significantly ameliorates the remodeling process by inhibiting cardiomyocyte apoptosis in 2 different experimental animal models of AMI. This may open the door for using anakinra to prevent postischemic cardiac remodeling and heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Tei, C., Ling, L. H., Hodge, D. O., Bailey, K. R., Oh, J. K., Rodeheffer, R. J., Tajik, A. J., & Seward, J. B. (1995) · PubMed · Cited by 1,547
Claycomb, W. C., Lanson, N. A., Stallworth, B. S., Egeland, D. B., Delcarpio, J. B., Bahinski, A., & Izzo, N. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2979 · Cited by 1,546
Ducharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L. E., Schoen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 808
Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P. (2001) · Circulation Research · doi:10.1161/hh1501.094396 · Cited by 598
Dinarello, C. A. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00023-3 · Cited by 582
Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A. G., Ginnetti, F., Dinarello, C. A., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.16.2079 · Cited by 485
Self-citationA randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Emsley, H. C. A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054882 · Cited by 445
The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1
Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373
Das, A., Xi, L., & Kukreja, R. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404706200 · Cited by 333
Self-citationGarcía, J. H., Liu, K. F., & Relton, J. K. (1995) · Europe PMC (PubMed Central) · Cited by 241
Granowitz, E. V., Porat, R., Mier, J. W., Pribble, J. P., Stiles, D. M., Bloedow, D. C., Catalano, M. A., Wolff, S. M., & Dinarello, C. A. (1992) · Cytokine · doi:10.1016/1043-4666(92)90078-6 · Cited by 220
Abbate, A., Biondi-Zoccai, G. G. L., Bussani, R., Dobrina, A., Camilot, D., Feroce, F., Rossiello, R., Baldi, F., Silvestri, F., Biasucci, L. M., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02959-5 · Cited by 203
Self-citationSuzuki, K., Murtuza, B., Smolenski, R. T., Sammut, I. A., Suzuki, N., Kaneda, Y., & Yacoub, M. H. (2001) · Circulation · doi:10.1161/hc37t1.094871 · Cited by 202
Cortés, A., Cascante, M., Cárdenas, M. L., & Cornish-Bowden, A. J. (2001) · Biochemical Journal · doi:10.1042/bj3570263 · Cited by 197
Salloum, F. N., Abbate, A., Das, A., Houser, J.-E., Mudrick, C. A., Qureshi, I. Z., Hoke, N. N., Roy, S. K., Brown, W. R., Prabhakar, S., et al. (2007) · AJP: Heart and Circulatory Physiology · doi:10.1152/ajpheart.91438.2007 · Cited by 187
Self-citationMulcahy, N. J., Ross, J., Rothwell, N. J., & Loddick, S. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705462 · Cited by 185
IL-1 Receptor Antagonist Prevents Apoptosis and Caspase-3 Activation after Spinal Cord Injury
Nesic, O., Xu, G.-Y., McAdoo, D., Westlund High, K., Hulsebosch, C., & Perez-Polo, R. (2001) · Journal of Neurotrauma · doi:10.1089/089771501750451857 · Cited by 178
Pathophysiologic role of myocardial apoptosis in post‐infarction left ventricular remodeling
Abbate, A., Biondi‐Zoccai, G. G., & Baldi, A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10174 · Cited by 178
Self-citationAcute myocardial infarction and heart failure: Role of apoptosis
Abbate, A., Bussani, R., Amin, M. S., Vetrovec, G. W., & Baldi, A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.04.010 · Cited by 177
Self-citationFurst, D. E. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.019 · Cited by 171
Severino, A., Campioni, M., Straino, S., Salloum, F. N., Schmidt, N., Herbrand, U., Frede, S., Toietta, G., Rocco, G. D., Bussani, R., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.006 · Cited by 125
Self-citationProstaglandin E 2 induces caspase-dependent apoptosis in rat cortical cells
Takadera, T., Yumoto, H., Tozuka, Y., & Ohyashiki, T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02449-1 · Cited by 120
A Role for Caspase-1 in Heart Failure
Merkle, S., Frantz, S., Schön, M. P., Bauersachs, J. K., Buitrago, M. A. B., Frost, R. J., Schmitteckert, E. M., Lohse, M. J., & Engelhardt, S. H. (2007) · Circulation Research · doi:10.1161/01.res.0000260203.55077.61 · Cited by 119
Wilson, H. L., Francis, S., Dower, S., & Crossman, D. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1202 · Cited by 116
Broberg, C. S., Pantely, G. A., Barber, B. J., Mack, G. K., Lee, K. A., Thigpen, T., Davis, L. E., Sahn, D. J., & Hohimer, A. R. (2003) · Journal of the American Society of Echocardiography · doi:10.1067/s0894-7317(03)00399-7 · Cited by 95
Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial Ischemia
Syed, F. M., Hahn, H. S., Odley, A. M., Guo, Y., Vallejo, J. G., Lynch, R. A., Mann, D. L., Bolli, R., & Dorn, G. W. (2005) · Circulation Research · doi:10.1161/01.res.0000166925.45995.ed · Cited by 88
Crossman, D. C., Morton, A. C., Gunn, J. P., Greenwood, J. P., Hall, A. S., Fox, K. A. A., Lucking, A. J., Flather, M. D., Lees, B., & Foley, C. E. (2008) · Trials · doi:10.1186/1745-6215-9-8 · Cited by 81
Abbate, A., Bussani, R., Biondi‐Zoccai, G., Santini, D., Petrolini, A., De‐Giorgio, F., Vasaturo, F., Scarpa, S., Severino, A., Liuzzo, G., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi419 · Cited by 78
Self-citationRubinstein, M., Dinarello, C. A., Oppenheim, J. J., & Hertzog, P. J. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00006-9 · Cited by 58
Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction
Patti, G., D’Ambrosio, A., Mega, S., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.032 · Cited by 51
MORTON, A., Arnold, N., GUNN, J., Varcoe, R. W., Francis, S., Dower, S., & Crossman, D. C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.026 · Cited by 48
Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy
Airaghi, L., Lettino, M., Manfredi, M. G., et al. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90430-1 · Cited by 44
Sun, C., Pang, J. S., Cheng, C., Cheng, H., Lee, Y., Ku, W., Hsiao, C., Chen, J., & Yang, C. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0590 · Cited by 41
Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway
Evans, I., Dower, S., Francis, S., Crossman, D. C., & Wilson, H. L. (2006) · Cytokine · doi:10.1016/j.cyto.2006.02.003 · Cited by 31
Patti, G., Mega, S., Pasceri, V., et al. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280409 · Cited by 26
Gottlieb, R. A. (2005) · Circulation Research · doi:10.1161/01.res.0000169466.84402.c1 · Cited by 10
Cited by
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
The inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
Regulation of the Inflammatory Response in Cardiac Repair
Frangogiannis, N. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.243162 · Cited by 1,194
Metadata
- Authors
- Abbate, A., Salloum, F. N., Vecile, E., Das, A., Hoke, N. N., Straino, S., Biondi-Zoccai, G. G. L., Houser, J.-E., Qureshi, I. Z., Ownby, E. D., Gustini, E., Biasucci, L. M., Severino, A., Capogrossi, M. C., Vetrovec, G. W., Crea, F., Baldi, A., Kukreja, R. C., & Dobrina, A.
- Venue
- Circulation
- Published
- 2008-05-20
- Volume
- 117
- Issue
- 20
- Pages
- 2670-2683
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2074130375
- Cited by
- 360
- References
- 40
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.